Talis Biomedical Corp
TLISDelisted Sep 20, 2024- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001584751
Talis Biomedical Corp was delisted on Sep 20, 2024; its insiders filed their last Form 4 on Sep 9, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $6.84M in total; Greenlight Capital was the only superinvestor holding it.
Q2 2024 vs. Q1 2024
How the institutions holding Talis Biomedical Corp changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 18 | 18 | 0 |
| Shares | 792.5K | 789.5K | −3.03K (−0.4%) |
| Value | $6.93M | $6.84M | −$92.5K (−1.3%) |
New holders (2)
Institutions that held Talis Biomedical Corp at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Steward Partners Investment Advisory, LLC | 147 | $1.27K | 0.00% |
| Bank of America Corp | 13 | $113 | 0.00% |
Sold out (2)
Institutions that held Talis Biomedical Corp at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| ADAR1 Capital Management, LLC | 300 | $2.63K |
| Wells Fargo & Company | 13 | $114 |